Categories AlphaGraphs, Earnings, LATEST, Technology
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite a 6% increase in revenues. The top-line also beat analysts’ estimates.
First-quarter revenues increased 6% year-over-year to $3.2 million and came in above analysts’ estimates. The company added 339 registered members during the three-month period.
Trxade reported a net loss of $1 million or $0.12 per share for the first quarter, compared to a loss of $0.7 million or $0.08 per share in the year-ago quarter. The bottom line missed analysts’ estimates.
Check this space to read management/analysts’ comments on Trxade’s Q1 2022 results
Shares of Trxade closed Monday’s trading lower. The stock has lost about 41% so far this year.
Prior Performance
Most Popular
Should investors worry about Micron’s (MU) weak Q4 results and guidance?
The semiconductor industry is a rapidly growing business segment that currently thrives on the digital transformation wave. The demand for memory chips and other semiconductor products increased over the years,
What has Bed Bath & Beyond (BBBY) outlined for this fiscal year?
Shares of Bed Bath & Beyond (NASDAQ: BBBY) were up on Friday, a day after the company delivered disappointing results for the second quarter of 2022. The company reported a
NKE Earnings: Highlights of Nike’s Q1 2023 results
Nike, Inc. (NYSE: NKE) has reported a decrease in net profit for the first quarter of 2023, despite a modest increase in revenues. The company's stock suffered a big loss
